Literature DB >> 32467320

Performance of gastrointestinal pathologists within a national digital review panel for Barrett's oesophagus in the Netherlands: results of 80 prospective biopsy reviews.

Esther Klaver1, Myrtle van der Wel2,3, Lucas Duits2, Roos Pouw2, Kees Seldenrijk4, Johan Offerhaus5, Mike Visser6, Fiebo Ten Kate5, Katharina Biermann7, Lodewijk Brosens5, Michael Doukas7, Clément Huysentruyt8, Arend Karrenbeld9, Gursah Kats-Ugurlu9, Jaap van der Laan10, Ineke van Lijnschoten8, Freek Moll11, Ariadne Ooms12, Jan Tijssen13, Sybren Meijer3, Jacques Bergman2.   

Abstract

AIMS: The histopathological diagnosis of low-grade dysplasia (LGD) in Barrett's oesophagus (BO) is associated with poor interobserver agreement and guidelines dictate expert review. To facilitate nationwide expert review in the Netherlands, a web-based digital review panel has been set up, which currently consists of eight 'core' pathologists. The aim of this study was to evaluate if other pathologists from the Dutch BO expert centres qualify for the expert panel by assessing their performance in 80 consecutive LGD reviews submitted to the panel.
METHODS: Pathologists independently assessed digital slides in two phases. Both phases consisted of 40 cases, with a group discussion after phase I. For all cases, a previous consensus diagnosis made by five core pathologists was available, which was used as reference. The following criteria were used: (1) percentage of 'indefinite for dysplasia' diagnoses, (2) percentage agreement with consensus diagnosis and (3) proportion of cases with a consensus diagnosis of dysplasia underdiagnosed as non-dysplastic. Benchmarks were based on scores of the core pathologists.
RESULTS: After phase I, 1/7 pathologists met the benchmark score for all quality criteria, yet three pathologists only marginally failed the agreement with consensus diagnosis (score 68.3%, benchmark 69%). After a group discussion and phase II, 5/6 remaining aspirant panel members qualified with all scores within the benchmark range.
CONCLUSIONS: The Dutch BO review panel now consists of 14 pathologists, who-after structured assessments and group discussions-can be considered homogeneous in their review of biopsies with LGD. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Entities:  

Keywords:  Barrett's oesophagus; digital pathology; quality assurance

Year:  2020        PMID: 32467320     DOI: 10.1136/jclinpath-2020-206511

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot.

Authors:  Nastazja Dagny Pilonis; Sarah Killcoyne; W Keith Tan; Maria O'Donovan; Shalini Malhotra; Monika Tripathi; Ahmad Miremadi; Irene Debiram-Beecham; Tara Evans; Rosemary Phillips; Danielle L Morris; Craig Vickery; Jon Harrison; Massimiliano di Pietro; Jacobo Ortiz-Fernandez-Sordo; Rehan Haidry; Abigail Kerridge; Peter D Sasieni; Rebecca C Fitzgerald
Journal:  Lancet Oncol       Date:  2022-01-11       Impact factor: 41.316

2.  Reproducibility and Feasibility of Classification and National Guidelines for Histological Diagnosis of Canine Mammary Gland Tumours: A Multi-Institutional Ring Study.

Authors:  Serenella Papparella; Maria Ines Crescio; Valeria Baldassarre; Barbara Brunetti; Giovanni P Burrai; Cristiano Cocumelli; Valeria Grieco; Selina Iussich; Lorella Maniscalco; Francesca Mariotti; Francesca Millanta; Orlando Paciello; Roberta Rasotto; Mariarita Romanucci; Alessandra Sfacteria; Valentina Zappulli
Journal:  Vet Sci       Date:  2022-07-13

3.  Impact of expert center endoscopic assessment of confirmed low grade dysplasia in Barrett's esophagus diagnosed in community hospitals.

Authors:  Esther A Nieuwenhuis; Sanne N van Munster; Wouter L Curvers; Bas L A M Weusten; Lorenza Alvarez Herrero; Auke Bogte; Alaa Alkhalaf; B Ed Schenk; Arjun D Koch; Manon C W Spaander; Thjon J Tang; Wouter B Nagengast; Jessie Westerhof; Martin H M G Houben; Jacques J G H M Bergman; Erik J Schoon; Roos E Pouw
Journal:  Endoscopy       Date:  2022-01-28       Impact factor: 9.776

4.  The utility of P53 immunohistochemistry in the diagnosis of Barrett's oesophagus with indefinite for dysplasia.

Authors:  Wladyslaw Januszewicz; Nastazja D Pilonis; Tarek Sawas; Richard Phillips; Maria O'Donovan; Ahmad Miremadi; Shalini Malhotra; Monika Tripathi; Adrienn Blasko; David A Katzka; Rebecca C Fitzgerald; Massimiliano di Pietro
Journal:  Histopathology       Date:  2022-06       Impact factor: 7.778

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.